Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

10.47
+0.28102.76%
Volume:1.06M
Turnover:10.96M
Market Cap:1.91B
PE:-102.65
High:10.50
Open:10.15
Low:10.08
Close:10.19
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.66
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-196.12
PE(LYR):3,265.05

Loading ...

Why Xeris Biopharma (XERS) Is Up 7.7% After Governance, IP, And Balance Sheet Moves - And What's Next

Simply Wall St.
·
Jul 05

Xeris Biopharma Director Nerissa Kreher Files Initial Beneficial Ownership Statement

Reuters
·
Jul 03

Xeris Biopharma Chief Legal Officer Beth Hecht Sells 16,666 Shares Worth $133,865.06

Reuters
·
Jul 03

Xeris Biopharma Grants 221,323 Inducement Rsus to 47 New Employees

Reuters
·
Jul 03

Xeris Taps CEO to Additionally Serve as Chairman

Dow Jones
·
Jun 30

Palvella Therapeutics Appoints Savara CEO Matt Pauls to Board of Directors

Reuters
·
Jun 30

Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026

Reuters
·
Jun 30

Xeris Announces Updates to Its Board of Directors

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Marla Persky to Transition to Lead Independent Director

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Appoints John Shannon as Chair of the Board

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Gets Notice of Allowance From US Patent and Trademark Office for New KEVEYIS Patent

MT Newswires Live
·
Jun 12

Xeris Biopharma gets USPTO notice of allowance for Keveyis patent extending protection to 2039

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Jun 11

Xeris Biopharma announces private exchange of convertible notes

TIPRANKS
·
Jun 11

BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes

Reuters
·
Jun 11

Xeris Biopharma retires USD 23 million of 8% convertible notes in cash-and-stock exchange

Reuters
·
Jun 11

Xeris Biopharma Announces Private Exchange of Convertible Notes

THOMSON REUTERS
·
Jun 11

Xeris Biopharma - to Retire $23 Mln Principal of Notes for $23 Mln Cash and Shares

THOMSON REUTERS
·
Jun 11

Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons

Reuters
·
Jun 09

Xeris Biopharma director Marla Persky sells 15,500 shares worth $91,433.95

Reuters
·
Jun 06